Clinical Trials Directory

Trials / Completed

CompletedNCT03169647

Evaluating the Effectiveness of Treatment for Metacognition in Moderate and Severe Traumatic Brain Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Kessler Foundation · Academic / Other
Sex
All
Age
18 Years – 59 Years
Healthy volunteers
Not accepted

Summary

Metacognition, in-the-moment awareness of performance while engaging in cognitive tasks, is negatively affected by traumatic brain injury (TBI). Metacognitive deficits can greatly reduce quality of life for individuals with TBI as functioning in this domain has been closely linked with successful independent living and community re-integration. Problematically, there are currently no empirically validated treatment options that address metacognitive deficits after TBI. Recent research in healthy samples demonstrates that specific listening interventions may alter neural activation in brain works associated with metacognition and can improve metacognitive functioning; however, it remains unknown if these effects generalize to individuals with TBI. Thus, the objective of the proposed study is to use a double-blind, placebo controlled randomized clinical trial to determine the efficacy of applying a specific listening intervention to improve metacognition after TBI and to employ functional magnetic resonance imaging (fMRI) to document the neural mechanisms by which the intervention operates.

Conditions

Interventions

TypeNameDescription
BEHAVIORALListening-based interventionParticipants will listen to pre-specified material on a CD

Timeline

Start date
2017-08-17
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2017-05-30
Last updated
2019-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03169647. Inclusion in this directory is not an endorsement.